Zodiac Partners II raised its all-cash tender offer for Destination XL Group to $0.84 per share and extended the expiration through early July, disclosing that 58% of outstanding shares had tendered as of the initial deadline. The new price represents a 5% increase from the prior $0.80 offer and carries a committed equity backstop, lifting the bid's credibility after DXL's board rejected earlier approaches as inadequate.

The tender results put Zodiac Partners within range of control but short of the 90% threshold required for a short-form merger under Delaware law. Destination XL trades at roughly $105 million market capitalization pre-announcement, operating 206 Big + Tall retail locations with annual revenue near $485 million. The company posted positive EBITDA in recent quarters but remains sub-scale in a consolidating specialty apparel sector, where landlords increasingly favor experiential formats over single-demographic footprints. Zodiac's revised offer prices DXL at approximately 0.22x trailing revenue, a discount to peer multiples but consistent with distressed specialty retail valuations.

The equity commitment matters. Private capital groups frequently walk from tender offers when acceptance falls below economically viable thresholds, leaving target companies with depressed trading prices and governance disruption. Zodiac's backstop removes that optionality, forcing DXL's board into a binary decision: negotiate a consensual transaction at or above $0.84, or defend the current strategy against a bidder now holding majority control if the tender closes. The board's public statement that it will "review" the revised offer signals acknowledgment of the new positioning, though no recommendation has issued. Institutional holders with 10%+ stakes—State Street, Vanguard, Dimensional—will determine outcome, and their silence thus far suggests either ongoing negotiations or internal committee review.

Specialty apparel has contracted 18% by store count since 2019, with Big + Tall formats particularly vulnerable to Amazon's algorithmic fit recommendations and direct-to-consumer entrants like Stitch Fix's extended sizing. DXL's value proposition relies on physical try-on and tailoring services, a defensible niche but one with minimal operating leverage. A private take-out at $0.84 would allow rationalization of the 206-store footprint without quarterly earnings pressure, likely targeting 150-160 locations in MSAs with sufficient density. The implied $88 million equity check at current tender levels positions Zodiac for an LBO structure with moderate leverage, assuming $40-45 million EBITDA and 3.5x debt multiple.

Allocators should watch institutional tender activity in the next 10 business days, which will determine whether Zodiac crosses 66.7% (board replacement threshold) or 90% (short-form merger). DXL's board faces a June 30 governance meeting where directors must either recommend the $0.84 offer or articulate a credible standalone plan that justifies rejection. If no counter-bidder emerges by mid-July—and none has surfaced despite a 45-day marketing process earlier this year—Zodiac will likely move to replace the board and execute the merger through long-form mechanics, adding 90-120 days to close but eliminating negotiation leverage.

The tell is the equity backstop. Zodiac would not commit incremental capital unless it had reviewed DXL's Q2 2026 financials and confirmed the asset performs within underwriting parameters. That certainty, more than the $0.04 price increase, shifts the probability distribution toward deal closure.